Skip to Content

Join the 'Melanoma' group to help and get support from people like you.

Melanoma News

Related terms: Cancer, Melanoma, Malignant Melanoma, Skin Cancer, Melanoma

Too Much Time in the Sun? Skin Patch Might Tell

Posted 9 days ago by Drugs.com

WEDNESDAY, Dec. 5, 2018 – A new mint-sized, battery-free patch that alerts wearers to potentially harmful sunlight exposure in real time might become a powerful weapon in preventing skin cancer. Powered by the sun while designed to measure its rays, the patch automatically transmits sun readings to a user's smartphone. It works wet or dry, is fully reusable, and weighs next to nothing. "In the ...

Global Melanoma Deaths Up Among Men, But Not Women

Posted 5 Nov 2018 by Drugs.com

MONDAY, Nov. 5, 2018 – Melanoma skin cancer death rates in men are on the rise in most countries, but are stable or declining for women in some, according to a new study. Researchers analyzed World Health Organization data from 33 countries between 1985 and 2015. Melanoma death rates in men were increasing in all but one nation. In all 33 countries, melanoma death rates were higher for men than ...

Drug Combo, Opdivo and Yervoy, Fights Melanoma That Has Spread to Brain

Posted 23 Aug 2018 by Drugs.com

THURSDAY, Aug. 23, 2018 – A combination of two drugs that work with the immune system can help beat back melanoma that has moved to the brain, an early clinical trial has found. The study included 94 patients with advanced melanoma that had invaded the brain. All were treated with two "immunotherapy" drugs – Opdivo (nivolumab) and Yervoy (ipilimumab) – which help the immune system find and ...

Frequent Skin Cancers May Signal Risk of Other Cancers, Too

Posted 9 Aug 2018 by Drugs.com

THURSDAY, Aug. 9, 2018 – People who have frequent recurrences of a common skin cancer may be at increased risk of a range of other cancers, a new study suggests. Researchers found the heightened risk among patients who'd had many bouts of basal cell carcinoma (BCC) – a highly treatable form of skin cancer diagnosed in over 3 million Americans each year. Patients who'd developed at least six ...

The Dark Side of Sunless Tanning

Posted 3 Aug 2018 by Drugs.com

FRIDAY, Aug. 3, 2018 – Don't kid yourself that using a sunless tanning product will prevent skin cancer. Unless you're willing to stop sunbathing altogether, you're still at risk for skin damage, researchers report. "For the most part, adults who use sunless tanning products continue to engage in risky tanning behaviors," said study leader Matthew Mansh, a dermatology resident at the University ...

Shield Yourself From the Summer Sun

Posted 29 Jul 2018 by Drugs.com

SATURDAY, July 28, 2018 – When you're out having fun in the sun this summer, remember to take steps to prevent sunburn. Along with being painful, sunburns can cause lasting damage that can lead to a number of skin problems, including skin cancer, warned Dr. Suzanne Olbricht, chief of dermatology at Beth Israel Deaconess Medical Center in Boston. "The sun's UV rays damage the DNA in the cells of ...

Gyms With Tanning Beds Send Mixed Message

Posted 27 Jul 2018 by Drugs.com

FRIDAY, July 27, 2018 – Gym rats are trying to get healthy. So why do so many U.S. gyms have tanning beds, researchers want to know. Since indoor tanning raises the risk of skin cancer, this common combo sends a conflicting message to gym users, University of Connecticut researchers say. "By pairing exercise with tanning beds, gyms send the message that tanning is part of a healthy lifestyle. It ...

Yes, Fingernail Cancer Is a Thing -- Just Ask This Beauty Queen

Posted 26 Jul 2018 by Drugs.com

THURSDAY, July 26, 2018 – Karolina Jasko was a high school senior when a nail salon worker pointed out the black vertical line on her right thumbnail. Because she typically painted her nails, the black line had gone unnoticed and unheeded, but then it started to show signs of infection. At that point, Jasko sought out medical advice and got her diagnosis: a melanoma of the nail. "My mom was ...

Immune-Based Therapy May Help When Melanoma Spreads to Brain

Posted 12 Jul 2018 by Drugs.com

THURSDAY, July 12, 2018 – A type of therapy that harnesses the immune system is giving new hope to people battling a once hopeless cancer – melanoma that's spread to the brain. New research involving more than 2,700 U.S. patients is confirming what specialists in the field have long known – that "checkpoint blockade" treatment can beat back these devastating tumors. "Physicians who treat ...

How to Use Sunscreens the Right Way

Posted 10 Jul 2018 by Drugs.com

TUESDAY, July 10, 2018 – Stick or spray-on sunscreens are essential tools against skin cancer, but it's important to use them the right way, a dermatologist says. "Sticks are easy for under the eyes and the backs of the hands, while spray sunscreens are often easier to apply on children," Dr. Debra Wattenberg said in an American Academy of Dermatology news release. "However, it's important to ...

With Summer Here, Check for Signs of Skin Cancer

Posted 1 Jul 2018 by Drugs.com

SATURDAY, June 30, 2018 – During the summer when people trade in their jackets and jeans for flip flops and bathing suits, more skin is exposed to the sun's harmful UV rays. Dr. Katherine Gordon, assistant professor of dermatology at UT Southwestern Medical Center in Dallas, said summer is the perfect time for people to get in the habit of checking their skin for signs of cancer. "We recommend ...

FDA Approves Mektovi (binimetinib) and Braftovi (encorafenib) in Combination for Unresectable or Metastatic Melanoma with BRAF Mutations

Posted 30 Jun 2018 by Drugs.com

On June 27, 2018, the Food and Drug Administration approved encorafenib and binimetinib (Braftovi and Mektovi, Array BioPharma Inc.) in combination for patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test. Approval was based on a randomized, active-controlled, open-label, multicenter trial (COLUMBUS; NCT01909453) in 577 ...

Array BioPharma Announces FDA Approval of Braftovi (encorafenib) in Combination with Mektovi (binimetinib) for Unresectable or Metastatic Melanoma with BRAF Mutations

Posted 30 Jun 2018 by Drugs.com

BOULDER, Colo., June 27, 2018 /PRNewswire/ – Array BioPharma Inc. (Nasdaq: ARRY) today announced that the U.S. Food and Drug Administration (FDA) has approved Braftovi capsules in combination with Mektovi tablets for the treatment of patients with unresectable or metastatic melanoma with a BRAFV600E or BRAFV600K mutation, as detected by an FDA-approved test. Braftovi is not indicated for the ...

Flight Attendants Show Higher Cancer Risks

Posted 26 Jun 2018 by Drugs.com

TUESDAY, June 26, 2018 – Flight attendants may face higher-than-average risks of breast and skin cancers, a new study finds – though the reasons why aren't yet clear. Harvard researchers found that compared with women in the general U.S. population, female flight attendants had a 51 percent higher rate of breast cancer. Meanwhile, their rates of melanoma and non-melanoma skin cancers were about ...

Novartis Receives FDA Approval of Tafinlar + Mekinist for Adjuvant Treatment of BRAF V600-Mutant Melanoma

Posted 4 Jun 2018 by Drugs.com

:Basel, April 30, 2018 - Novartis announced today that the US Food and Drug Administration (FDA) has approved Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations, as detected by an FDA-approved test, and involvement of lymph node(s), following complete resection. The FDA granted the combination B ...

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Melanoma - Metastatic, Skin Cancer

Related Drug Support Groups

Opdivo, Keytruda, nivolumab, interferon alfa-2b, pembrolizumab, aldesleukin, Intron A, Sylatron, Yervoy, view more... talimogene laherparepvec, DTIC-Dome, Proleukin, dacarbazine, ipilimumab, temozolomide, peginterferon alfa-2b, Imlygic